Skip to main content

WOLVERINE ASSET MANAGEMENT LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1279891 CHICAGO, IL

Position in JAZZ

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$561,460
+$311,536 QoQ
Shares Held
2,330
+76.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#379
of 646 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JAZZ Over Time

Shares Held

Position Value (USD)

Derivatives in JAZZ

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$1,132,559
PutShares
4,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WOLVERINE ASSET MANAGEMENT LLC holds $7,557,835 across 34 Biotechnology names. JAZZ ranks #5 (7.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 JAZZ
Jazz Pharmaceuticals plc
This page
2,330 $561,460

All Filings in JAZZ

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,132,559 4,700
2026-06-30 $561,460 2,330
2026-03-31 $132,335 700
2026-03-31 $249,924 1,322
2025-12-31 $224,740 1,322
2025-12-31 $544,000 3,200
2025-09-30 $817,160 6,200
2025-09-30 $11,203 85
2025-06-30 $445,704 4,200
2025-03-31 $186,225 1,500
2024-12-31 $1,366,965 11,100
2024-09-30 $3,787,940 34,000
2024-06-30 $3,628,820 34,000
2024-06-30 $1,686,760 15,804
2024-03-31 $4,094,280 34,000
2024-03-31 $1,313,059 10,904
2023-12-31 $4,182,000 34,000
2023-12-31 $713,892 5,804
2023-09-30 $1,204,309 9,304
2023-09-30 $5,747,136 44,400
2023-06-30 $5,392,695 43,500
2023-06-30 $1,116,225 9,004
2023-03-31 $1,521,832 10,400
2022-12-31 $685,033 4,300
2021-06-30 $251,538 1,416
2021-03-31 $175,547 1,068
2020-12-31 $253,516 1,536
2020-03-31 $389,185 3,902